HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
about
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyRedox Control of Multidrug Resistance and Its Possible Modulation by AntioxidantsThe Nrf2/HO-1 Axis in Cancer Cell Growth and ChemoresistanceEpidermal growth factor stimulates nuclear factor-κB activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cellsIn vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells.Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to BortezomibGasotransmitters in cancer: from pathophysiology to experimental therapy.Heme oxygenase-1: emerging target of cancer therapy.hnRNPK-regulated PTOV1-AS1 modulates heme oxygenase-1 expression via miR-1207-5p.Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells.Targeting of heme oxygenase-1 as a novel immune regulator of neuroblastoma.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation.Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo.microRNA-494 Favors HO-1 Expression in Neuroblastoma Cells Exposed to Oxidative Stress in a Bach1-Independent Way.
P2860
Q26740191-888FAFD9-765B-4A0F-82B8-D6E5FD042A68Q26765805-4032E580-9B7E-43CE-97A4-590FE032A24FQ26772298-125B9440-8D90-439F-B683-688390F5ACE4Q34046939-FFD2B169-C957-44CF-A7DB-7055975E9D76Q35048614-D7AB8CFF-D188-4295-BBCB-FD6C755AA2E3Q35972588-42C446B3-5F82-4F69-BED9-264ABA8F5530Q37656625-9DEAF602-DCE0-4A24-BAAD-78F0A0DD811FQ38426058-87599BA7-0014-4653-881B-9B2CAD800377Q38754460-61AA2682-5F6C-4396-B17E-4153D98BD0ACQ38790184-40ECAE89-FD25-4FB7-8E25-C01966BB47EEQ38817604-3462A059-98C1-449C-B700-DA2987D7D060Q38869922-6D77E6DF-83A3-43B4-8588-86C27F70E8D0Q39285687-9EB44AF4-B0ED-40C6-B3E5-A5A7E6B40BFEQ44315979-A9F767CB-7184-4462-9BB8-E62E8C67D861Q55370004-21251152-849B-4C65-8836-729019786704
P2860
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@ast
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@en
type
label
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@ast
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@en
prefLabel
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@ast
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@en
P2093
P1476
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
@en
P2093
Alessia Parodi
Anna Lisa Furfaro
Cinzia Domenicotti
Lorenzo Moretta
Maria Adelaide Pronzato
Mariapaola Nitti
Nicola Traverso
Sabrina Piras
Umberto Maria Marinari
P304
P356
10.1016/J.BBADIS.2013.12.008
P407
P577
2013-12-28T00:00:00Z